Ovarian cancer is one of the most aggressive neoplastic diseases in women. It is composed of different types of carcinoma with distinct clinicopathological and molecular features. There are several research areas that need to be urgently addressed in order to gain more insight into this devastating disease and provide promise in developing new therapeutic regimens to improve the clinical outcome in ovarian cancer patients. This special issue provides a timely opportunity to publish those studies that aim at exploring the molecular and translational aspects of ovarian cancer. Both original research articles and succinct review papers are all welcome. It is expected that this new special issue on ovarian cancer will become a useful resource for all investigators and clinicians who are interested in ovarian cancer research and will inspire new research directions in the years to come. Potential topics include, but are not limited to:

• Molecular pathogenesis and molecular signature of different types of ovarian carcinoma
• Potential molecular targets for anticancer regimens, especially those targeting multiple cancer-related pathways
• New biomarkers for detection and prognostic prediction
• Analysis of The Cancer Genome Atlas in ovarian cancer

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jo/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable: